Company: NCEL
Filing Date: 2025-03-03
Form Type: F-4/A
Source: 0001213900-25-018981
Chunk: 781

Company: NewcelX Ltd.
Filing Date: 2025-03-03
Form: F-4/A
Chunk 781
---
            |          — |     | —            |   |     | —             |   |     |       |           — |   |
| Stock based compensation                                      |     |             — |     |   |       — |     | —        |   |     |            |    164,907 |     | —            |   |     | —             |   |     |       |     164,907 |   |
| Defined pension plan adjustments                              |     |             — |     |   |       — |     | —        |   |     |            |          — |     | —            |   |     | (107,280      | ) |     |       |    (107,280 | ) |
| Net loss                                                      |     |             — |     |   |       — |     | —        |   |     |            |          — |     | (12,172,029  | ) |     | —             |   |     |       | (12,172,029 | ) |
| BALANCE, DECEMBER 31, 2023                                    |     |    35,671,780 |     |   | 733,413 |     | (64,858  | ) |     |            | 61,029,437 |     | (70,373,484  | ) |     | (158,071      | ) |     |       |  (8,833,563 | ) |

The accompanying notes are an integral part of these financial statements.

Annex F-120

NLS PHARMACEUTICS LTD.
STATEMENTS OF CASH FLOWS

| Cash Flows From Operating Activities:                                           |     | For the Years Ended December 31, 
 2023                             |             |   |     | 2022 |             |   |     |        2021 |   |
|:--------------------------------------------------------------------------------|:----|:---------------------------------|------------:|:--|:----|:-----|------------:|:--|:----|------------:|:--|
| Net loss                                                                        |     | $                                | (12,172,029 | ) |     | $    | (16,495,680 | ) |     | (11,946,078 | ) |
| Adjustments to reconcile net loss to net cash used in operating activities:     |     |                                  |             |   |     |      |             |   |     |             |   |
|